Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of budesonide effervescent tablets in active eosinophilic esophagitis
2014-001484-12Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in eosinophilic esophagitis (EoE) comparing Budesonide effervescent tablets with Placebo (2 arms). Primary endpoint: Clinico-pathological remission rate. Started Apr 2015; status: completed.
02
Drugs
budesonide
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2014-001484-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001484-12.